Sera Prognostics, Inc. (SERA) Financials
SERA Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 90.1 million | 14.6 million |
2023-06-30 | 96.7 million | 15.5 million |
2023-03-31 | 105.6 million | 15.4 million |
2022-12-31 | 116.3 million | 17.4 million |
SERA Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -7.6 million | 1.2 million |
2023-06-30 | -8.0 million | 1.4 million |
2023-03-31 | -4.9 million | 1.3 million |
2022-12-31 | -7.4 million | 1.3 million |
SERA Net Income
No data available :(
SERA Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 46.1 million | - | 1.5 million |
2023-06-30 | 63.8 million | - | 2.4 million |
2023-03-31 | 70.8 million | - | 2.1 million |
2022-12-31 | 82.7 million | - | 2.8 million |
SERA Shares Outstanding
SERA Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | 26000 | 3.5 million | 3.3 million | 1.4 million |
2023-06-30 | 47000 | 3.7 million | 4.9 million | 2.9 million |
2023-03-31 | 39000 | 4.1 million | 4.4 million | 2.8 million |
2022-12-31 | 193000 | 3.5 million | 3.9 million | 3.1 million |
SERA Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | 42000 | 44000 |
2023-06-30 | 123000 | 80000 |
2023-03-31 | 100000 | 62000 |
2022-12-31 | 65000 | 59000 |
SERA
Price: $10.85
52 week price:
Earnings Per Share: -1.16 USD
P/E Ratio: -6.44
Exchange: NGM
Sector: Healthcare
Industry: Diagnostics & Research
Volume: 1300
Market Capitalization: 322.3 million